Aliskiren抑制LPS诱导HUVECs新生血管的形成及可能机制

摘要

目的:研究阿利吉仑(aliskiren)对脂多糖(LPS)诱导人脐静脉内皮细胞(HUVECs)新生血管形成能力的影响及可能的机制.方法:常规培养的HUVECs随机分为空白组和肾素组,ELISA法测定炎性细胞因子肿瘤坏死因子-α(TNF-α)和细胞间黏附分子-1(ICAM-1)水平,Western blot法检测Toll样受体4(TLR4)和ICAM-1的蛋白水平.将常规培养的HUVECs随机分为空白对照组、LPS模型组以及aliskiren低剂量(1μmol/L)、中剂量(10μmol/L)和高剂量(100μmol/L)组.MTT法和BrdU法检测HUVECs的增殖能力,Transwell法测定HUVECs的迁移率,以HUVECs在Matrigel胶上形成管腔结构情况来判断其血管形成能力.ELISA测定炎性细胞因子TNF-α、ICAM-1和单核细胞趋化蛋白-1(MCP-1)的水平,RT-PCR和Western blot法检测肾素、TLR4、基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)的mRNA和蛋白水平.结果:肾素能够刺激HUVECs炎症因子的分泌及TLR4的表达;aliskiren呈浓度依赖性抑制HUVECs增殖、迁移及新生血管形成,降低MCP-1、TNF-α、IL-6水平及肾素、MMP-2、MMP-9的表达,抑制TLR4表达(P<0.05).结论:Aliskiren能够有效抑制LPS诱导HUVECs新生血管形成能力,可能与其下调肾素表达抑制TLR4途径介导的炎症反应及MMP-2、MMP-9生成有关.%AIM:To investigate the inhibitory effect of aliskiren on the angiogenesis of human umbilical vein endothelial cells ( HUVECs) induced by lipopolysaccharide ( LPS) and to explore its possible mechanism.METHODS:HUVECs were cultured and randomly divided into blank group and renin group.The levels of tumor necrosis factor-α(TNF-α) and intercellular adhesion molecule-1 (ICAM-1) in the culture supernatant were detected by ELISA.The protein levels of Toll-like receptor 4 ( TLR4) and ICAM-1 in the HUVECs were determined by Western blot.HUVECs were cul-tured and randomly divided into control group, LPS group, low-dose (1μmol/L) aliskiren group, middle-dose (10μmol/L) aliskiren group and high-dose (100 μmol/L) aliskiren group.The proliferation of HUVECs was detected by MTT and BrdU assays.The mobility of HUVECs was measured by Transwell assay.The formation of the vessels was judged by ob-serving the formation of the luminal structure by HUVECs in Matrigel.The levels of TNF-α, ICAM-1 and monocyte chemo-tactic protein 1 ( MCP-1) in the culture supernatant were measured by ELISA.The expression of renin, TLR4, matrix me-talloproteinases-2 (MMP-2) and matrix metalloproteinases-9 (MMP-9) at mRNA and protein levels in the HUVECs was determined by RT-PCR and Western blot.RESULTS:Renin stimulated the expression of inflammatory factors and TLR4 in the HUVECs.Aliskiren inhibited the growth, migration and angiogenesis of HUVECs in a dose-dependent manner, de-creased the levels of TNF-α, ICAM-1 and MCP-1 and the expression of renin, MMP-2 and MMP-9, and inhibited TLR4 expression (P<0.05).CONCLUSION:Aliskiren inhibits LPS-induced angiogenesis of HUVECs, which may be related to the down-regulation of renin expression, the inhibition of TLR4-mediated inflammatory reaction, and the formation of MMP-9 and MMP-2.